Cargando…

Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells

Metabolic alterations contribute to prostate cancer development and progression; however, the role of the central metabolic regulator AMP-activated protein kinase (AMPK) remains controversial. The androgen receptor (AR), a key driver of prostate cancer, regulates prostate cancer cell metabolism by d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurmeister, Sarah, Ramos-Montoya, Antonio, Neal, David E., Fryer, Lee G D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116520/ https://www.ncbi.nlm.nih.gov/pubmed/25003216

Ejemplares similares

Identification of potential therapeutic targets in prostate cancer through a cross‐species approach
por: Jurmeister, Sarah, et al.
Publicado: (2018)

A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
por: Pertega‐Gomes, Nelma, et al.
Publicado: (2015)

Hydrazinobenzoylcurcumin inhibits androgen receptor activity and growth of castration-resistant prostate cancer in mice
por: Wu, Min, et al.
Publicado: (2015)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors
por: Xue, Caroline, et al.
Publicado: (2022)

Activation of p53 and destabilization of androgen receptor by combinatorial inhibition of MDM2 and MDMX in prostate cancer cells
por: Chopra, Harman, et al.
Publicado: (2017)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Androgen receptor footprint on the way to prostate cancer progression
por: Hodgson, Myles C., et al.
Publicado: (2011)

PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells
por: Liu, Wei, et al.
Publicado: (2021)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
por: Sharma, Naomi L., et al.
Publicado: (2014)

Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer
por: Ware, Kathryn E., et al.
Publicado: (2016)

Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2016)

Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
por: Koochekpour, Shahriar, et al.
Publicado: (2014)

The role of androgen receptors in vascular and cell proliferation of the prostate adenocarcinomas
por: Pănuş, Andrei, et al.
Publicado: (2020)

ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells
por: Levina, Elina, et al.
Publicado: (2015)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso, Mayarling Francisca, et al.
Publicado: (2021)

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
por: Zadra, Giorgia, et al.
Publicado: (2014)

A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
por: Zadra, Giorgia, et al.
Publicado: (2014)

GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition
por: Kim, Yejin, et al.
Publicado: (2021)

Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
por: Li, Xin, et al.
Publicado: (2015)

Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer
por: Titus, Mark A., et al.
Publicado: (2012)

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015)

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
por: Oh, Su Jung, et al.
Publicado: (2012)

Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells
por: Logan, Ian R., et al.
Publicado: (2016)

CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
por: Wang, Tao, et al.
Publicado: (2014)

AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
por: Rae, Colin, et al.
Publicado: (2019)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Continued Androgen Signalling Inhibition improves Cabazitaxel Efficacy in Prostate Cancer
por: Mout, Lisanne, et al.
Publicado: (2021)

Inhibiting androgen receptor nuclear entry in castration-resistant prostate cancer
por: Pollock, Julie A., et al.
Publicado: (2016)

Structural and functional association of androgen receptor with telomeres in prostate cancer cells
por: Zhou, Junying, et al.
Publicado: (2013)

V-ATPase-dependent repression of androgen receptor in prostate cancer cells
por: Licon-Munoz, Yamhilette, et al.
Publicado: (2018)

Detecting predictive androgen receptor modifications in circulating prostate cancer cells
por: Steinestel, Julie, et al.
Publicado: (2015)

Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy
por: Yamada, Eijiro, et al.
Publicado: (2016)

Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome
por: Leach, Damien A., et al.
Publicado: (2015)

P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation
por: Cavalca, Alexandre Matheus Baesso, et al.
Publicado: (2022)

Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor
por: Rajamahanty, Srinivas, et al.
Publicado: (2010)

Androgen Receptor and Poly(ADP-ribose) Glycohydrolase Inhibition Increases Efficiency of Androgen Ablation in Prostate Cancer Cells
por: Zhang, Manqi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6i8ldorhg1i5b03lprb7hkhhsr